Hematopoietic stem cell and gene therapy corrects primary neuropathology and behavior in mucopolysaccharidosis IIIA mice.

MLA

Langford-Smith, Alexander, et al. “Hematopoietic Stem Cell and Gene Therapy Corrects Primary Neuropathology and Behavior in Mucopolysaccharidosis IIIA Mice.” Molecular Therapy : The Journal of the American Society of Gene Therapy, vol. 20, no. 8, Aug. 2012, pp. 1610–21. EBSCOhost, https://doi.org/10.1038/mt.2012.82.

APA

Langford-Smith, A., Wilkinson, F. L., Langford-Smith, K. J., Holley, R. J., Sergijenko, A., Howe, S. J., Bennett, W. R., Jones, S. A., Wraith, J., Merry, C. L., Wynn, R. F., & Bigger, B. W. (2012). Hematopoietic stem cell and gene therapy corrects primary neuropathology and behavior in mucopolysaccharidosis IIIA mice. Molecular Therapy : The Journal of the American Society of Gene Therapy, 20(8), 1610–1621. https://doi.org/10.1038/mt.2012.82

Chicago

Langford-Smith, Alexander, Fiona L Wilkinson, Kia J Langford-Smith, Rebecca J Holley, Ana Sergijenko, Steven J Howe, William R Bennett, et al. 2012. “Hematopoietic Stem Cell and Gene Therapy Corrects Primary Neuropathology and Behavior in Mucopolysaccharidosis IIIA Mice.” Molecular Therapy : The Journal of the American Society of Gene Therapy 20 (8): 1610–21. doi:10.1038/mt.2012.82.